AI in Diagnostics: Opportunities for Transformation
The medtech industry is brimming with AI startups promising to revolutionize healthcare—but how many of those innovations are truly transformative? A panel at LSI Europe ’24 took a clear-eyed look at what it takes to move from promise to impact. The discussion, moderated by Andrew Pieprzyk of Hologic, featured Pau Rodriguez (Methinks AI), Dror Zur (Magentiq Eye), David Zakariaie (Senseye), and Gokce Gun (We Venture Capital), each bringing a distinct vantage point to the table. Together, they offered a grounded yet forward-looking perspective on how artificial intelligence is reshaping diagnostic workflows across stroke, colorectal cancer, mental health, and beyond. AI in Diagnostics: Trust, Transparency, and Training Data If AI in diagnostics is to succeed, transparency must be baked into its foundation. Zur, CEO of Magentiq Eye, emphasized that the quality and characteristics of a dataset determine the strength of an AI tool. “It’s important to show what type of data...